← Back to All Filings

Medpace Officer Files Intent to Sell $10.9M in Stock (MEDP)

Low SignificanceNovember 12, 2025 at 8:02:14 AM EST

Medpace Holdings, Inc.

$MEDP144CIK: 0001668397

Subscribe to track MEDP

Premium users can add ticker alerts and receive realtime notification updates.

Filing Summary

Medpace Officer Files Intent to Sell $10.9M in Stock (MEDP)

Company: Medpace Holdings, Inc. (MEDP) Form: 144 | Filed: 2025-11-12 Significance: Low

Insider: BURWIG SUSAN E Title: Officer | Relationship: Officer

Transaction: • Type: Proposed Sale • Shares: 18,000 • Price: $605.00 • Value: $10,890,000 • Owned After: Not Stated

Key Insight: An officer has filed a notice of intent to sell 18,000 shares. The transaction represents a very small fraction (0.066%) of the company's market capitalization.

Market Context: This follows a pattern of recent sales by the same insider, totaling 12,000 shares over the prior three months. The sale is small relative to the company's $16.6B market cap.

View Full Filing

This is PUBLIC SEC data for educational purposes. Not investment advice.

Comprehensive Analysis

SEC Filing Analysis: Medpace Holdings, Inc. (MEDP)

Executive Summary

  • Trading Significance: Low
  • Key Takeaway: An officer of Medpace Holdings, Inc. has filed a Form 144, indicating an intent to sell 18,000 shares of common stock valued at approximately $10.9 million.
  • Market Impact: The proposed sale is of low materiality, representing a negligible percentage of the company's market capitalization and outstanding shares, suggesting minimal market impact.

Company Information

FieldValue
CompanyMedpace Holdings, Inc.
Ticker SymbolMEDP
CIK0001668397
IndustrySERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH

Insider Information

FieldValue
NameBURWIG SUSAN E
CIK0001677418
Title/PositionOfficer
RelationshipOfficer

Transaction Details

FieldValue
Form Type144
Transaction Date2025-11-11 (Approximate)
Transaction CodeS (Proposed Sale)
Security TypeCommon Stock
Shares Involved18,000
Price Per Share$605.00 (Implied)
Total Value$10,890,000.00
Shares Owned AfterNot Stated
Ownership TypeNot Stated

Financial Impact Assessment

Transaction Materiality

MetricValue
Transaction Value$10,890,000.00
% of Market Cap0.066%
Shares Transacted18,000
% of Shares Outstanding0.064%
Materiality AssessmentLow

Impact Evaluation

  • Market Cap Context: For a company with a market capitalization of $16.60 billion, this $10.9 million transaction is considered routine and not financially significant.
  • Transaction Significance: The sale constitutes just 0.066% of the market cap and 0.064% of shares outstanding. These percentages are well below the thresholds for moderate or high significance, indicating a low-impact event.

Market Impact Analysis

Stock Impact Prediction

  • Direction: Neutral
  • Reasoning: The transaction size is immaterial relative to Medpace's large market capitalization. Form 144 filings are notices of intent and are common for executives managing personal finances or exercising options.

Volume & Sentiment

  • Expected Volume Impact: Minimal. The number of shares is unlikely to cause significant price or volume fluctuations in a stock with a multi-billion dollar market cap.
  • Sentiment Indicator: Neutral. The sale is not large enough to signal a change in the insider's outlook on the company, especially given the context of prior sales.

Additional Context

Transaction Notes

  • Origin of Shares: The shares to be sold were acquired via a stock option exercise on August 5, 2024.
  • Prior Sales: The filing discloses that the same insider sold a total of 12,000 shares in two separate transactions within the past three months, indicating a pattern of periodic selling.
Topics:#SECFiling#InsiderTrading#MEDP#Form144#InsiderSell#Medpace#StockMarket#MarketAnalysis

Get Real-Time Alerts

Join our community to receive instant notifications when high-significance filings are published

Important Disclaimer

This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.

Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.